Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Switch of Asparaginase Formulation Based on Antibody Monitoring in Adults with Philadelphia-Negative Adult Lymphoblastic Leukemia. Results of the Graall-2014 Trial

Blood (2024) 144 (Supplement 1): 1434.

https://doi.org/10.1182/blood-2024-199110

Published: 2024

Journal Articles

Therapy Related Myeloid Neoplasms Following PARP Inhibitors : Real-Life Experience

Blood (2022) 140 (Supplement 1): 12335–12338.

https://doi.org/10.1182/blood-2022-163478

Published: 2022

Journal Articles

Therapy Related Myeloid Neoplasm Post PARP Inhibitors: Potential Clonal Selection.

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-139971

Published: 2020

Journal Articles

Monitoring Asparaginase Activity in 21 Patients with Extranodal NK/T-Cell Lymphoma Shows a Very High Proportion of Asparaginase Inactivation

Arnaud Jaccard, MD PhD, Sammara Chaubard, MD, Jean-François Benoist, MD, Lucile Couronne, Laure Philippe, MD, Emmanuel Gyan, MD PhD, Ronan Le Calloch, MD, Aline Moignet Autrel, MD, Rémy Gressin, MD, Jacques Vargaftig, MD PhD, Aline Clavert, MD, Emmanuel Bachy, MD PhD, Olivier Hermine, MD PhD

Blood (2018) 132 (Supplement 1): 5351.

https://doi.org/10.1182/blood-2018-99-118439

Published: 2018

Journal Articles

Phase 2 Trial of Single Agent Gedatolisib (PF-05212384), a Dual PI3K/mTOR Inhibitor, for Adverse Prognosis and Relapse/Refractory AML: Clinical and Transcriptomic Results

Jacques Vargaftig, MD PhD, Hassan Farhat, MD, Lionel Ades, MD PhD, Adrien Briaux, Camille Benoist, Isabelle Turbiez, Norbert Vey, MD PhD, Sylvie Glaisner, MD, Céline Callens, PharmD, PhD

Blood (2018) 132 (Supplement 1): 5233.

https://doi.org/10.1182/blood-2018-99-117485

Published: 2018

Journal Articles

A Series of 116 Therapy-Related Myeloid Neoplasms (t-MN) Patients from 2 French Comprehensive Cancer Centers

Hind Bennani, PharmD, Véronique Saada, PharmD, Christophe Willekens, MD, Jacques Vargaftig, MD

Blood (2015) 126 (23): 1322.

https://doi.org/10.1182/blood.V126.23.1322.1322

Published: 2015

Journal Articles

Acute Common Iliac Artery Thrombosis with Concurrent Pulmonary Embolism Revealing AML M2: Role of Elevated Plasma Tissue Factor Activity

Hind Bennani, PharmD, Raphaël Coscas, MD, Marc Coggia, MD, Patrick Van Dreden, PhD, Marc Vasse, PharmD, Jacques Vargaftig, MD

Blood (2015) 126 (23): 4722.

https://doi.org/10.1182/blood.V126.23.4722.4722

Published: 2015

Journal Articles

Ferric Carboxymaltose Alone or Combined with Erythropoietin Allows a Modest Increase in Hemoglobin for the Treatment of Cancer-Related Anemia in Advanced Cancer Patients

Cécile Blanc, Marie-Eglantine Dujaric, Caroline Giard, PharmD, Bernard Asselain, MD PhD, Isabelle Ferry, PharmD, Sylvie Glaisner, MD, Céline Callens, PharmD, PhD, Jacques Vargaftig, MD

Blood (2014) 124 (21): 4884.

https://doi.org/10.1182/blood.V124.21.4884.4884

Published: 2014

Journal Articles

IL10 and IL10:IL6 Ratio in CSF Is Useful at Diagnosis but Also in the Assessment of Therapeutic Response in Patients with Primary Central Nervous System Lymphoma (PCNSL)

Ludovic Nguyen, MD, Myrto Costopoulos, PharmD, Marie-Laure Tanguy, PharmD, Caroline Houillier, MD, Sylvain Choquet, MD, Hind Bennani, PharmD, Rwaida Elias, MD, Marine Armand, PharmD, Khe Hoang-Xuan, MD PhD, Sylvie Glaisner, MD, Sandra Malak, MD, Jacques Vargaftig, MD, Geraldine Faivre, MD, Frederic Davi, MD PhD, Helene Merle Beral, MD PhD, Magali Le Garff-Tavernier, PharmD, PhD, Carole Soussain, MD PhD

Blood (2014) 124 (21): 1619.

https://doi.org/10.1182/blood.V124.21.1619.1619

Published: 2014

Journal Articles

Fludarabine Plus Cyclophosphamide and Rituximab In Waldenström's Macroglobulinemia: Results In 55 Patients

Véronique Leblond, Laetitia Compain, Vincent Levy, MD, PhD, Jérôme Tamburini, MD, PhD, Alain Delmer, MD, Jacques Vargaftig, MD, Brigitte Pégourié-Bandelier, MD, Beatrice Mahe, MD, Steven Le Guill, MD, PhD, Olivier Tournilhac, MD, PhD, Elisabeth Brottier-Mancini, MD, Richard Delarue, MD, Agnès Buzyn, MD, PhD, Michel Maigre, MD, Claude Gardin, MD, Sylvain Choquet, MD

Blood (2010) 116 (21): 1757.

https://doi.org/10.1182/blood.V116.21.1757.1757

Published: 2010

Journal Articles

Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34 − fraction

David C. Taussig, Jacques Vargaftig, Farideh Miraki-Moud, Emmanuel Griessinger, Kirsty Sharrock, Tina Luke, Debra Lillington, Heather Oakervee, Jamie Cavenagh, Samir G. Agrawal, T. Andrew Lister, John G. Gribben, Dominique Bonnet

Blood (2010) 115 (10): 1976–1984.

https://doi.org/10.1182/blood-2009-02-206565

Published: 2010

Includes: Supplemental data

Journal Articles

Fludarabine Plus Cyclophosphamide and Rituximab (RFC) in Waldenström’s Macroglobulinemia (WM): Results in 21 Patients (pts).

Jacques Vargaftig, MD, Brigitte Pegourié-Bandelier, MD, Béatrice Mahé, MD, Steven Le Gouill, MD, PhD, Elisabeth Brottier-Mancini, MD, Richard Delarue, MD, Agnès Buzyn, MD, PhD, Martine Raphael, MD, Sylvain Choquet, MD, Véronique Leblond, MD

Blood (2006) 108 (11): 4727.

https://doi.org/10.1182/blood.V108.11.4727.4727

Published: 2006

Journal Articles

Rapamycin inhibits growth and survival of D816V-mutated c-kit mast cells

Blood (2006) 108 (3): 1065–1072.

https://doi.org/10.1182/blood-2005-06-2433

Published: 2006

Journal Articles

Efficacy and Safety of Cladribine in Adult Systemic Mastocytosis : A French Multicenter Study of 33 Patients.

Olivier Lortholary, MD, PhD, Jacques Vargaftig, MD, Frederic Feger, PhD, Fabienne Palmerini, Richard Delarue, MD, Valerie Ferriole, Jean Marie Launay, MD, Isabelle Bonte, MD, Stephane Barete, MD, Christine Bodemer, MD, Sylvie Freytag, MD, Philippe Casassus, MD, Michel Arock, PhD, Patrice Dubreuil, PhD, Olivier Hermine, MD, PhD.

Blood (2004) 104 (11): 661.

https://doi.org/10.1182/blood.V104.11.661.661

Published: 2004

NARROW

Switch of Asparaginase Formulation Based on Antibody Monitoring in Adults with Philadelphia-Negative Adult Lymphoblastic Leukemia. Results of the Graall-2014 Trial

Therapy Related Myeloid Neoplasms Following PARP Inhibitors : Real-Life Experience

Therapy Related Myeloid Neoplasm Post PARP Inhibitors: Potential Clonal Selection.

Monitoring Asparaginase Activity in 21 Patients with Extranodal NK/T-Cell Lymphoma Shows a Very High Proportion of Asparaginase Inactivation

Phase 2 Trial of Single Agent Gedatolisib (PF-05212384), a Dual PI3K/mTOR Inhibitor, for Adverse Prognosis and Relapse/Refractory AML: Clinical and Transcriptomic Results

A Series of 116 Therapy-Related Myeloid Neoplasms (t-MN) Patients from 2 French Comprehensive Cancer Centers

Acute Common Iliac Artery Thrombosis with Concurrent Pulmonary Embolism Revealing AML M2: Role of Elevated Plasma Tissue Factor Activity

Ferric Carboxymaltose Alone or Combined with Erythropoietin Allows a Modest Increase in Hemoglobin for the Treatment of Cancer-Related Anemia in Advanced Cancer Patients

IL10 and IL10:IL6 Ratio in CSF Is Useful at Diagnosis but Also in the Assessment of Therapeutic Response in Patients with Primary Central Nervous System Lymphoma (PCNSL)

Fludarabine Plus Cyclophosphamide and Rituximab In Waldenström's Macroglobulinemia: Results In 55 Patients

Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34 − fraction

Fludarabine Plus Cyclophosphamide and Rituximab (RFC) in Waldenström’s Macroglobulinemia (WM): Results in 21 Patients (pts).

Rapamycin inhibits growth and survival of D816V-mutated c-kit mast cells

Efficacy and Safety of Cladribine in Adult Systemic Mastocytosis : A French Multicenter Study of 33 Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only